T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...

In a new study, researchers examined the efficacy and impact of CD19 CAR T cell therapy on B cells, specifically exploring its ability to deplete B cells in deep tissues and understand the therapeutic ...

In a paper published this year in Neuron, Motte and colleagues described treatment with autologous CD19-targeted CAR T cells in two patients with concomitant myasthenia gravis and Lambert-Eaton ...

If donor CAR-T cell therapy does indeed work, as posited in this paper, it could mean the therapy is more scalable than it would be otherwise. Joining Ira to talk about this study and its potential ...

Penn Medicine is advancing cancer treatment with its work in CAR T-cell therapy, an innovative immunotherapy that is reshaping the fight against blood cancers and rare genetic diseases. Penn Medicine ...

Chimeric antigen receptor (CAR) T-cell therapy has been an exciting area of development for autoimmune disease treatment. Previous reports had not mentioned any particular constellation of adverse ...

"CAR-T cell therapy is enormously promising ... "It's also the first paper to uncover the mechanisms. We found the exact same pathophysiology we've seen in brain fog syndromes that occur after ...

This article explores the current landscape and future potential of cell therapies, including CAR T-cell and stem cell-based ...

Like other cell therapies, CAR T cell therapy uses a modified cell either from the patient or from a donor to impact the way a person’s immune system functions. In this case, the modified cell is a ...

Chimeric antigen receptor T-cell therapy, or CAR-T cell therapy, is one type of immunotherapy. Sometimes likened to a "smart drug" or "living drug," CAR-T cell therapy relies on genetically ...

A recently developed cancer treatment called chimeric antigen receptor T-cell therapy (CAR T-cell therapy, for short) offers hope to people whose diffuse large B-cell lymphoma (DLBCL) has proved ...